Soubra Ayman, Hayward Daniel, Dahm Philipp, Goldfarb Robert, Froehlich Jerry, Jha Gautam, Konety Badrinath R
Department of Urology, University of Minnesota, MMC 394 Mayo, 420 Delaware Street SE, Minneapolis, MN, 55455, USA.
Departments of Radiology, University of Minnesota, Minneapolis, MN, USA.
World J Urol. 2016 Sep;34(9):1229-37. doi: 10.1007/s00345-016-1772-z. Epub 2016 Feb 4.
The purpose of this study was to assess the diagnostic accuracy of 18F-fluorodeoxyglucose with positron emission tomography and computed tomography (FDG-PET-CT) to predict nodal metastases in patients with bladder cancer (BC) scheduled to undergo radical cystectomy (RC).
We retrospectively reviewed records of patients diagnosed with BC and scheduled to undergo RC at our center from January 2011 through February 2015, who also underwent FDG-PET-CT at the time of diagnosis. All patients underwent RC and an extended pelvic lymph node dissection as the reference standard. The primary endpoints were the sensitivity, specificity and overall accuracy of FDG-PET-CT in detecting lymph node metastasis. We also examined its accuracy in identifying distant metastasis. In addition, we conducted a protocol-driven systematic review and meta-analysis of accuracy of FDG-PET-CT for preoperative staging of BC, as compared to CT alone, as reported in individual studies. To assess the methodological quality of eligible studies, we used the QUADAS-2 tool (a revised tool for the Quality Assessment of Diagnostic Accuracy Studies) and pooled diagnostic accuracy measures using Meta-DiSc statistical software.
For detecting nodal metastases in 78 patients, the sensitivity of FDG-PET-CT was 0.56 (95 % CI 0.29-0.80) and the specificity, 0.98 (95 % CI 0.91-1.00). Pooled sensitivity and specificity for detecting lymph node metastasis were 0.57 and 0.95, respectively. Positive likelihood ratio was 9.02. All lesions that were suspicious for distant metastasis were found to be positive on biopsy.
FDG-PET-CT was more accurate than CT alone in staging BC in patients undergoing surgery. Standardization of FDG-PET-CT protocol and cost-effectiveness analysis are required before widespread implementation of this technology.
本研究旨在评估18F-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描(FDG-PET-CT)对计划接受根治性膀胱切除术(RC)的膀胱癌(BC)患者淋巴结转移的诊断准确性。
我们回顾性分析了2011年1月至2015年2月在本中心诊断为BC并计划接受RC且在诊断时也接受了FDG-PET-CT检查的患者记录。所有患者均接受了RC及扩大盆腔淋巴结清扫术作为参考标准。主要终点是FDG-PET-CT检测淋巴结转移的敏感性、特异性和总体准确性。我们还检查了其在识别远处转移方面的准确性。此外,我们根据方案进行了系统评价和荟萃分析,比较了FDG-PET-CT与单独CT对BC术前分期的准确性,这些准确性数据来自各项独立研究报告。为评估符合条件研究的方法学质量,我们使用了QUADAS-2工具(诊断准确性研究质量评估的修订工具),并使用Meta-DiSc统计软件汇总诊断准确性指标。
对于78例患者淋巴结转移的检测,FDG-PET-CT的敏感性为0.56(95%CI 0.29 - 0.80),特异性为0.98(95%CI 0.91 - 1.00)。检测淋巴结转移的汇总敏感性和特异性分别为0.57和0.95。阳性似然比为9.02。所有可疑远处转移的病变活检均为阳性。
在接受手术的BC患者中,FDG-PET-CT在分期方面比单独CT更准确。在广泛应用该技术之前,需要对FDG-PET-CT方案进行标准化并进行成本效益分析。